Gene recombination sheds light on Alzheimer's failures, suggests HIV drugs could help

A new understanding of amyloid precursor protein (APP) variants from researchers at Sanford Burnham Prebys Medical Discovery Institute and University of California San Diego could help explain why Alzheimer's disease candidates targeting the amyloid pathway

Read the full 358 word article

How to gain access

Continue reading with a
two-week free trial.